1
|
Hu X, Qi J, Cheng K, He W, Zhang K, Zhao C, Lu Y, Zhu X. Effectiveness of prophylactic capsular tension ring implantation during cataract surgery in highly myopic eyes. J Cataract Refract Surg 2024; 50:1030-1036. [PMID: 39313860 DOI: 10.1097/j.jcrs.0000000000001495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2024] [Accepted: 05/19/2024] [Indexed: 09/25/2024]
Abstract
PURPOSE To assess the effectiveness of prophylactic capsular tension ring (CTR) implantation during cataract surgery in highly myopic eyes. SETTING Eye and Ear, Nose, and Throat Hospital of Fudan University, Shanghai, China. DESIGN Prospective cohort study. METHODS Consecutive highly myopic patients treated with cataract surgery were recruited and randomized to undergo CTR implantation or not. The outcomes compared between the 2 groups included axial lens position (ALP), intraocular lens (IOL) decentration and tilt, area of anterior capsule opening, severity of anterior capsular opacification (ACO), and posterior capsular opacification (PCO) at 1 year postoperatively. RESULTS A total of 55 highly myopic eyes with CTRs implanted and 55 without were included in the analysis. At 1 year postoperatively, no significant differences were detected between the CTR and non-CTR groups for the mean ALP, IOL decentration, or tilt (all P > .05). However, the CTR group had a significantly larger area of anterior capsule opening (23.62 ± 3.30 mm2 vs 21.85 ± 2.30 mm2, P = .003), and less severe ACO (P = .033) and PCO (PCO-3 mm: 0.06 ± 0.13 vs 0.13 ± 0.20, P = .038; PCO-C: 0.15 ± 0.18 vs 0.25 ± 0.26, P = .026) than the non-CTR group. The corrected distance visual acuity, prediction error, and higher-order aberrations did not differ between the 2 groups (all P > .05). CONCLUSIONS In highly myopic eyes, although prophylactic CTR implantation can reduce the severity of capsular contraction and opacification, it does not significantly affect postoperative IOL stability or visual outcomes.
Collapse
Affiliation(s)
- Xiaoxin Hu
- From the Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China (Hu, Qi, Cheng, He, Zhang, Zhao, Lu, Zhu); NHC Key laboratory of Myopia and Related Eye Diseases; Key laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China (Hu, Qi, Cheng, He, Zhang, Zhao, Lu, Zhu); Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China (Hu, Qi, Cheng, He, Zhang, Zhao, Lu, Zhu)
| | | | | | | | | | | | | | | |
Collapse
|
2
|
He W, Cheng K, Zhao L, Liu S, Huang Z, Zhang K, Du Y, Zhou X, Lu Y, Zhu X. Long-Term Outcomes of Posterior Capsular Opacification in Highly Myopic Eyes and Its Influencing Factors. Ophthalmol Ther 2023; 12:1881-1891. [PMID: 37138195 PMCID: PMC10287617 DOI: 10.1007/s40123-023-00711-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2022] [Accepted: 04/04/2023] [Indexed: 05/05/2023] Open
Abstract
INTRODUCTION The purpose of this study was to evaluate the long-term outcomes of posterior capsular opacification (PCO) in highly myopic eyes and its influencing factors. METHODS Patients undergoing phacoemulsification with intraocular lens implantation and followed up for 1-5 years were included in this prospective cohort study. The severity of PCO was evaluated using EPCO2000 software system, with the area of central 3.0 mm (PCO-3 mm) and within the capsulorhexis (PCO-C) both being analyzed. Percentage of eyes after Nd:YAG capsulotomy, as well as clinically significant PCO (defined as eyes with visual-impairing PCO or after capsulotomy), were also included as outcome variables. RESULTS A total of 673 highly myopic eyes [axial length (AL) ≥ 26 mm] and 224 control eyes (AL < 26 mm) were analyzed. The mean follow-up time was 34.0 ± 9.0 months. PCO was more severe in highly myopic eyes compared with controls with regard to higher EPCO scores (P < 0.001 for both PCO-3 mm and PCO-C), higher capsulotomy rate (P = 0.001), higher clinically significant PCO rate (P < 0.001) and shorter PCO-free survival time (P < 0.001). Extreme myopia (AL ≥ 28 mm) would further aggravate PCO in terms of higher EPCO scores (PCO-3 mm: P = 0.017; PCO-C: P = 0.013) and higher clinically significant PCO rate (P = 0.024) compared with other myopic eyes. In highly myopic eyes, AL [odds ratio (OR) 1.124, P = 0.004] and follow-up duration (OR 1.082, P < 0.001) were independent risk factors for clinically significant PCO after cataract surgery. CONCLUSION Highly myopic eyes had more severe PCO in the long term. Longer AL and follow-up duration were associated with higher risk of PCO. CLINICAL TRIAL REGISTRATION The study was registered at ClinicalTrials.gov (NCT03062085).
Collapse
Affiliation(s)
- Wenwen He
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Kaiwen Cheng
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Liangliang Zhao
- Department of Ophthalmology, The Second Hospital of Jilin Univesity, Changchun, 120021, People's Republic of China
| | - Shuyu Liu
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Zhiqian Huang
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Keke Zhang
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Yu Du
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Xingtao Zhou
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Yi Lu
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China.
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China.
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China.
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China.
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China.
| | - Xiangjia Zhu
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China.
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China.
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China.
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China.
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China.
| |
Collapse
|
3
|
Li X, Li J, Sun D, Ma T, Chen W, Ye Z, Li Z. Development and Validation of a Prediction Model for Nd:YAG Laser Capsulotomy: A Retrospective Cohort Study of 9768 eyes. Ophthalmol Ther 2023; 12:1893-1912. [PMID: 37133707 PMCID: PMC10287599 DOI: 10.1007/s40123-023-00723-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 04/20/2023] [Indexed: 05/04/2023] Open
Abstract
INTRODUCTION Posterior capsular opacification (PCO) is the most common complication of cataract surgery. In this study, we develop a model to quantitatively predict the probability of Nd:YAG laser capsulotomy for vision-threatening PCO to improve the life quality of postoperative patients. METHODS A registry analysis of cataract procedures performed between the years 2010 and 2021. Following the screening of 16,802 patients (25,883 eyes), 9768 patients (eyes) were enrolled. The cohort was randomly divided into two groups: training (n = 6838) and validation (n = 2930). To identify relevant risk factors, univariate, multivariate, and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm Cox regression analysis were employed, and a nomogram was created to demonstrate the prediction result. RESULTS At 5 years, the overall cumulative incidence of Nd:YAG laser capsulotomy was 12.0% (1169/9768). The following variables were included in the prediction model: sex [hazard ratio (HR) = 1.53, 95% CI 1.32-1.76], age (HR = 0.71, 95% CI 0.56-0.88), intraocular lens (IOL) material (HR = 2.65, 95% CI 2.17-3.24), high myopia (HR = 2.28, 95% CI 1.90-2.75), and fibrinogen (HR = 0.79, 95% CI 0.72-0.88). In the validation cohort, the area under the curve (AUC) of 1-, 3-, and 5-year predictions for Nd:YAG laser capsulotomy were 0.702, 0.691, and 0.688, respectively. For a subgroup of patients with high myopia, the protective effect of hydrophobic IOL disappeared (HR = 0.68, 95% CI 0.51-1.12, P = 0.127). CONCLUSION This model could predict the probability of Nd:YAG laser capsulotomy for vision-threatening PCO after cataract surgery by taking into account factors such as age, gender, IOL material, high myopia, and fibrinogen. Meanwhile, implantation of a hydrophobic IOL in individuals with high myopia did not demonstrate a protective impact against vision-threatening PCO.
Collapse
Affiliation(s)
- Xuanlong Li
- Medical School of Chinese PLA, Beijing, 100853 China
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Jinglan Li
- Medical School of Chinese PLA, Beijing, 100853 China
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Di Sun
- Medical School of Chinese PLA, Beijing, 100853 China
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Tianju Ma
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Wenqian Chen
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Zi Ye
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Zhaohui Li
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| |
Collapse
|